These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7878869)

  • 1. A short course of cyclosporin A combined with anti-CD4 and/or anti-TCR MAb treatment induces long-term acceptance of kidney allografts in the rat.
    Lácha J; Chadimová M; Havlícková J; Brock J; Matl I; Volk HD; Lehmann M
    Transplant Proc; 1995 Feb; 27(1):125-6. PubMed ID: 7878869
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-CD4 therapy induces a donor-specific, organ-nonspecific tolerance in allogeneic kidney graft recipients.
    Kuttler B; Lehmann M; Lacha J; Brock J; Hahn HJ
    Transplant Proc; 1994 Apr; 26(2):728-9. PubMed ID: 8171628
    [No Abstract]   [Full Text] [Related]  

  • 3. CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
    Watson CJ; Davies HF; Cobbold SP; Rasmussen A; Rebello PR; Thiru S; Waldmann H; Calne RY; Metcalfe SM
    Transplant Proc; 1995 Feb; 27(1):123-4. PubMed ID: 7878859
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance induction by anti-CD4 MAb treatment in a rat kidney transplantation model.
    Volk HD; Siegling A; Platzer C; Brock J; Emmrich F; Lehmann M
    Transplant Proc; 1994 Dec; 26(6):3155-6. PubMed ID: 7998100
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of the spleen in the establishment and maintenance of anti-CD4-induced transplant nonresponsiveness.
    Lehmann M; Havlickova J; Risch K; Pulya K; Lacha J; Brock J; Volk HD
    Transplant Proc; 1995 Feb; 27(1):121-2. PubMed ID: 7878853
    [No Abstract]   [Full Text] [Related]  

  • 6. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H; Hara MH; Miyahara T; Tanigawa M; Matsuzaki Y; Onitsuka T; Shibata K; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Iwaya M; Miyasaka M; Kimura H
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract]   [Full Text] [Related]  

  • 7. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
    Hara MH; Tanigawa M; Matsuzaki M; Onitsuka T; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Iwaya M; Yamaguchi A; Masaki Y; Miyasaka M; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-CD4 monoclonal antibody therapy on rat small bowel allograft survival.
    Bowles MJ; Webster GA; Wood RF; Pockley AG
    Transplant Proc; 1994 Jun; 26(3):1605. PubMed ID: 7913268
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic effects of 15-deoxyspergualin with cyclosporine and the TCR-targeted monoclonal antibody R73 to induce specific unresponsiveness to skin allografts in rats.
    Schorlemmer HU; Dickneite G; Kurrle R; Seiler FR
    Transplant Proc; 1995 Feb; 27(1):414-6. PubMed ID: 7879044
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of chronic rejection in permanent accepted renal allografts in anti-CD4 treated rats.
    Risch K; Heemann U; Graser E; Nebe B; Nizze H; Lacha J; Brock J; Volk HD; Lehmann M
    Clin Nephrol; 1996 May; 45(5):358-60. PubMed ID: 8738673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of combined treatment with total lymphoid irradiation, cyclosporin A, and anti-CD4 monoclonal antibodies in a hamster-to-rat heart transplantation model.
    Steinbrüchel DA; Madsen HH; Nielsen B; Kemp E; Larsen S; Koch C
    Transplant Proc; 1991 Feb; 23(1 Pt 1):579-80. PubMed ID: 1990614
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of the anti-CD4-induced permanent acceptance of rat renal allografts.
    Lehmann M; Kuttler B; Siegling A; Gordalla A; Riedel H; Lacha J; Hahn HJ; Brock J; Volk HD
    Transplant Proc; 1993 Oct; 25(5):2859-60. PubMed ID: 8212264
    [No Abstract]   [Full Text] [Related]  

  • 15. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival.
    Sablinski T; Sayegh MH; Kut JP; Tilney NL; Milford EL; Kupiec-Weglinski JW
    Transplantation; 1992 Jan; 53(1):219-21. PubMed ID: 1346346
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay.
    Steinbrüchel DA; Lillevang ST; Nielsen B; Kemp E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):427-9. PubMed ID: 8438364
    [No Abstract]   [Full Text] [Related]  

  • 18. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
    Oko A; Krzymański M; Deja A; Pawliczak E; Idasiak-Piechocka I
    Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined monoclonal antibody therapy in experimental small bowel transplantation.
    Bowles MJ; Wood RF; Pockley AG
    Transplant Proc; 1996 Oct; 28(5):2510. PubMed ID: 8907926
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
    Sablinski T; Sayegh MH; Kut JP; Hancock WW; Milford EL; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):268-9. PubMed ID: 1990530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.